BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15061967)

  • 1. [Preliminary study on effect of pentoxifylline in treatment of extrinsic allergic alveolitis].
    Tong ZH; Chen BM; Dai HP; Wang C; Guzman J; Costabel U
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):482-5. PubMed ID: 15061967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrinsic allergic alveolitis: inhibitory effects of pentoxifylline on cytokine production by alveolar macrophages.
    Tong Z; Chen B; Dai H; Bauer PC; Guzman J; Costabel U
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):234-9. PubMed ID: 14989392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline].
    Tong ZH; Dai HP; Chen BM; Wang C; Guzman J; Costabel U
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jul; 26(7):415-8. PubMed ID: 12921647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone.
    Tong Z; Dai H; Chen B; Abdoh Z; Guzman J; Costabel U
    Chest; 2003 Oct; 124(4):1526-32. PubMed ID: 14555589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
    Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
    Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) inductions.
    Freeburn RW; Armstrong L; Millar AB
    Eur Cytokine Netw; 2005; 16(1):5-16. PubMed ID: 15809201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages.
    Marques LJ; Zheng L; Poulakis N; Guzman J; Costabel U
    Am J Respir Crit Care Med; 1999 Feb; 159(2):508-11. PubMed ID: 9927365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis.
    Dai H; Guzman J; Chen B; Costabel U
    Chest; 2005 Jan; 127(1):251-6. PubMed ID: 15653992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia.
    Cai M; Bonella F; Dai H; Sarria R; Guzman J; Costabel U
    Immunobiology; 2013 Jun; 218(6):930-7. PubMed ID: 23199585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 12, interleukin 18, and tumor necrosis factor alpha release by alveolar macrophages: acute and chronic hypersensitivity pneumonitis.
    Ye Q; Nakamura S; Sarria R; Costabel U; Guzman J
    Ann Allergy Asthma Immunol; 2009 Feb; 102(2):149-54. PubMed ID: 19230467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effects of alpha 1 protease inhibitor on the production of IL-1 and TNF alpha by alveolar macrophages in patients with lung cancer].
    Ameshima S; Ishizaki T; Takahashi H; Kishi Y; Sasaki F; Nakai T; Miyabo S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):873-80. PubMed ID: 1630052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal methylprednisolone differentially regulates the expression of TNF and IL-10 in human alveolar macrophages.
    Frankenberger M; Häussinger K; Ziegler-Heitbrock L
    Int Immunopharmacol; 2005 Feb; 5(2):289-99. PubMed ID: 15652760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro.
    Cu A; Ye Q; Sarria R; Nakamura S; Guzman J; Costabel U
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):147-54. PubMed ID: 20560295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumour necrosis factor receptors (CD120a and CD120b) on bronchoalveolar cells.
    Gaede KI; Fitschen J; Ernst M; Martinet N; Schlaak M; Müller-Quernheim J
    Cytokine; 1999 Aug; 11(8):611-6. PubMed ID: 10433809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pentoxifylline and somatostatin on tumour necrosis factor production by human pulmonary macrophages.
    Balibrea JL; Arias-Díaz J; García C; Vara E
    Circ Shock; 1994 Jun; 43(2):51-6. PubMed ID: 7834820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro.
    Zhang J; Tachado SD; Patel N; Zhu J; Imrich A; Manfruelli P; Cushion M; Kinane TB; Koziel H
    J Leukoc Biol; 2005 Sep; 78(3):665-74. PubMed ID: 16000387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of bronchioloalveolar carcinoma-derived C-X-C chemokines by tumor infiltrating inflammatory cells.
    Wislez M; Philippe C; Antoine M; Rabbe N; Moreau J; Bellocq A; Mayaud C; Milleron B; Soler P; Cadranel J
    Inflamm Res; 2004 Jan; 53(1):4-12. PubMed ID: 15021975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pentoxifylline inhibits experimental bleomycin-induced fibrosing alveolitis].
    Entzian P; Gerlach C; Gerdes J; Schlaak M; Zabel P
    Pneumologie; 1997 Apr; 51(4):375-80. PubMed ID: 9221384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.